I[n]{.smallcaps} eukaryotic cells, the number, polarity, and organization of cellular microtubules is controlled by the microtubule-organizing center. In the yeast *Saccharomyces cerevisiae*, the microtubule-organizing center is the spindle pole body (SPB)^1^ that resides in the nuclear envelope. Cryoelectron microscopy shows that the SPB is composed of six major layers ([@B5]). Although the SPB is an extremely large organelle, estimated to be ∼20 times the size of the yeast nuclear pore complex, each layer may be composed of only one or a few proteins that are present in high copy numbers ([@B5]). Consequently, the SPB may contain a total of ∼20--30 unique proteins. A number of SPB proteins have been identified. These include Cdc31p ([@B2]; [@B35]), Kar1p ([@B27]; [@B36]), Cmd1 ([@B11]), Spc42p ([@B9]), Spc97p ([@B18]), Spc98p ([@B12]), Spc110p ([@B17]), and Tub4p ([@B22]; [@B33]; [@B37]). Tub4p is the yeast γ-tubulin. It forms a 6S complex with Spc97p and Spc98p ([@B18]) that has been localized to both the nucleoplasmic and cytoplasmic sides of the SPB ([@B12]; [@B37]). Microtubule nucleation is thought to be accomplished through the action of this γ-tubulin complex ([@B22]; [@B37]). Microtubules that extend from the nucleoplasmic face of the SPB form the mitotic spindle, while microtubules that extend from the cytoplasmic face of the SPB form the cytoplasmic microtubule array that serves to orient the spindle.

Recently, we described an additional component of the yeast SPB, Stu2p ([@B41]). Stu2p is unique among the known SPB components because it is a microtubule-binding protein that interacts laterally with microtubules. This property of Stu2p suggests that it may play a role in the attachment, organization, and/or dynamics of microtubules at the SPB. Although Stu2p binds microtubules, its presence at the SPB does not appear to require the presence of microtubules. Therefore, we concluded that Stu2p must also interact with at least one other component of the SPB. In this report, we describe Spc72p, a protein identified by its ability to interact with Stu2p. Like Stu2p, Spc72p is a component of the SPB, but unlike Stu2p, Spc72p is not a microtubule-binding protein. Spc72p is an essential protein, and we describe the effect of an *spc72* temperature-sensitive mutation on microtubule assembly and function in vivo.

Materials and Methods {#MaterialsMethods}
=====================

Strains and Media
-----------------

Yeast strains used in this study are listed in Table [I](#TI){ref-type="table"}. Yeast extract/peptone/dextrose (YPD) and synthetic dextrose (SD) media were prepared as described by [@B30]. YPGal is YPD with 2% galactose substituted for 2% dextrose. Plates containing 5-fluoroorotic acid (5-FOA) were prepared as described by [@B4]. To depolymerize microtubules, nocodazole was added to the culture at 10 μg/ml for 1 h at 26°C, and then for 1 h at 4°C. To arrest cells in the cell cycle, 3 μg/ml α-factor or 0.1 M hydroxyurea were added to the culture for 3 h at 26°C.

Two-hybrid Screen
-----------------

The two-hybrid screen was performed as described by [@B10]. The pAS2 vector and an *S. cerevisiae* cDNA library fused to the Gal4p activation domain were obtained from S. Elledge (Baylor College of Medicine, Houston, TX). The bait plasmid, encoding the entire Stu2p fused to the COOH-terminal end of the Gal4p DNA binding domain, was made as follows: *STU2* was amplified from yeast genomic DNA by PCR using primers that contain XbaI and SalI sites, respectively. The 2688-bp PCR product was digested with XbaI and SalI, and was ligated into the NheI and SalI sites of pAS2 ([@B10]), resulting in plasmid pXC180.

pXC180 and the cDNA library were cotransformed into the host strain Y190. Transformants were selected for growth on SD plates containing 25 mM 3-amino-triazole. A transformation efficiency test indicated that ∼10^6^ Trp^+^ Leu^+^ transformants were obtained in this experiment. 63 colonies appeared on the 3-amino-triazole plates. 50 of these colonies showed varying levels of β-galactosidase activity by the filter assay. These 50 colonies were struck on plates containing 10 μg/ml cycloheximide to select cells that had lost the pXC180 plasmid; 42 of these still showed β-galactosidase activity, and were not pursued further. Plasmids were isolated from the remaining 10 strains that had lost pXC180. Each of the 10 plasmids was then introduced into Y190, together with pAS1-SNF1. None of the proteins encoded by the 10 cDNA clones interacted with Snf1p. Partial sequencing was performed to identify genes corresponding to these cDNA clones.

SPC72 Constructs
----------------

Selected plasmids used in this study are listed in Table [II](#TII){ref-type="table"}. A genomic DNA fragment containing *SPC72* was amplified from yeast chromosomal DNA by PCR using primers that introduced a BamHI and NheI site at each end, respectively, and was TA-cloned into the pCRII vector (Invitrogen Corp., Carlsbad, CA). The resulting plasmid pXC204 was cut with BamHI and NheI, and the 3.6-kb fragment was cloned into pXC157 to create pXC214. pXC157 is pRS415 ([@B32]) with the SstI site destroyed. A 3.5-kb KpnI-SstII fragment of pXC214 was subcloned into the KpnI and SstII sites of pRS416 to create pXC255.

*SPC72* was also placed under the control of *GAL1* promoter. A 0.7-kb EcoRI-BamHI fragment containing *GAL1* promoter (Liu, et al., 1992) was cloned into the BamHI site of pRS416 ([@B32]) to create pWP97. The entire *SPC72* open reading frame was amplified by PCR and subcloned into pCRII to make pXC215. A 2.0-kb BamHI--SpeI fragment of pXC215 was cloned into the BamHI and XbaI sites of pWP97 to create pXC231. To switch the *URA3* marker on pXC231 to *LEU2*, the 2.8-kb XhoI-SstII fragment of pXC231 was ligated into the XhoI and SstII sites of pRS415 to make pXC254.

*SPC72* constructs for use in the two-hybrid screen were created as follows: The *SPC72* open reading frame was amplified from yeast chromosomal DNA by PCR using primers that introduced a BamHI and XhoI at the 5′ and 3′ ends, respectively. The 2-kb BamHI-XhoI fragment was cloned into the same sites in pACT2 and pAS2 to create pXC219 and pXC281, respectively.

A *SPC72-GFP* fusion was created as follows: PCR was used to amplify *SPC72* from genomic DNA. One of the primers was designed so that the resulting PCR fragment had a BglII site inserted immediately before the *SPC72* stop codon. The PCR product was subcloned into pXC214 (see above) to create pXC223. A BamHI--BamHI fragment containing the S65T version of green fluorescent protein (GFP; [@B13]) was subcloned into the BglII site of pXC223 to create pXC224 containing the *SPC72-GFP* fusion construct. pXC224 was transformed into CUY1111. Leu^+^ transformants were plated on 5-FOA to select cells that had lost the *URA3*-based plasmid. pXC224 was able to complement the *SPC72* disruption. To place the *SPC72-GFP* construct in a YEp plasmid, a 5.1-kb XhoI-- SstII fragment from pXC224 was subcloned into the XhoI/SstII sites of pRS425 ([@B8]) to make pXC226. To place *SPC72-GFP* under the control of *GAL1* promoter, the 3.5-kb PstI--SstII fragment from pXC224 was then subcloned into the same sites on pXC254 (see above) to create pXC266. The *P[gal1]{.smallcaps}-SPC72-GFP* was placed into an integrating vector by cloning the HindIII-SstII fragment from pXC266 into the same sites in pRS406 ([@B32]) to create pXC287. pXC287 was linearized by cutting with StuI, which cuts within the *URA3* gene, and was integrated into the *URA3* chromosomal locus to create CUY1115.

Epitope-tagged versions of Spc72p were constructed as follows: to make *SPC72-HA*, a DNA fragment encoding three tandem copies of the hemagglutinin (HA) epitope was amplified by PCR from the plasmid GTEPI (B. Futcher, Cold Spring Harbor Laboratory). The PCR product has a BglII site at each end. It was digested with BglII and ligated into the BglII site on pXC223 to create the YCp plasmid pXC265. To construct *SPC72-myc*, a DNA fragment encoding two copies of the myc epitope was amplified by PCR from the plasmid pB303 (D. Pellman, Harvard Medical School, Boston, MA). The PCR product contained a BglII site at each end, and was subcloned into the pCRII vector to make pXC242. The BglII fragment containing myc~2~ was ligated into the BglII site of pXC223 to produce the YCp plasmid pXC248. *SPC72-myc* was also placed into YEp plasmids. The 2.5-kb XhoI--NotI fragment of pXC248 was subcloned into the XhoI--NotI sites of pRS425 and pRS426 to make pXC262 and pXC264, respectively.

Disruption of SPC72
-------------------

To disrupt the *SPC72* gene, two 69-mers were used to amplify the *URA3* gene from pRS416 ([@B32]). The resulting DNA fragment contained the entire *URA3* gene and 50 bp of sequence immediately upstream of the *SPC72* start codon and 50 bp of sequence immediately downstream of the *SPC72* stop codon. This fragment was transformed into a diploid strain CUY546. A Ura^+^ transformant, CUY1109, containing the correct *spc72-*Δ*1*::*URA3* deletion was identified by PCR analysis. To convert the *URA3* marker at the *SPC72* locus to the *HIS3* marker, a 3-kb EcoRI fragment from the plasmid B2388 (from G. Fink, Massachusetts Institute of Technology, Cambridge, MA) was transformed into CUY1109. One of these His^+^ transformants, CUY1110, contains the *spc72-*Δ*1*::*HIS3* deletion.

Immunoprecipitation Experiments
-------------------------------

Mouse monoclonal antibodies 12CA5 and 9E10, which recognize the HA and myc epitopes, respectively, were purchased from Berkeley Antibody Co. (Berkeley, CA). Rabbit anti-Stu2p polyclonal antibody was generated against the 385 carboxy-terminal amino acids of Stu2p. Yeast extracts were prepared essentially as described in [@B34]. These extracts were first diluted into PBS (4.3 mM Na~2~HPO~4~, 1.4 mM KH~2~PO~4~) containing 1% Tween 20. The salt concentration was then adjusted to 50 mM with NaCl. The diluted extracts were incubated with appropriate antibodies at 4°C for 1 h in the presence of protease inhibitors (10 μg/ml leupeptin, 10 μg/ml pepstatin, and 1 mM phenylmethylsulfonylfluoride). The reactions were then spun at 16,000 *g* for 10 min, and the supernatants were incubated with 10 mg/ml protein G--conjugated agarose beads (Sigma Chemical Co., St. Louis, MO) for 1 h at 4°C. Each reaction was then washed four times with PBS containing 50 mM NaCl and 1% Tween 20. The beads were resuspended in SDS sample buffer, incubated at 100°C for 10 min, and analyzed by SDS-PAGE ([@B19]) and immunoblotting.

Generation of SPC72 Mutants
---------------------------

*SPC72* was amplified by PCR under mutagenic conditions ([@B24]). A 100-μl PCR reaction contained 40 ng pXC204 template DNA, 7 mM MgCl~2~, 200 μM dATP, 1 mM dTTP, dGTP, and dCTP, 0.5 μM MnCl~2~, and 5 U of Taq DNA polymerase. The cycling parameters were as follows: 1 min at 94°C, 1 min at 57°C, and 3 min at 72°C. 30 cycles were performed. PCR products were purified, digested with SstI and BglII, and ligated into pXC214 digested with the same two enzymes so that the 1.4-kb mutagenized *SPC72* fragment replaced the wild-type *SPC72* fragment. 9,000 bacterial transformants were pooled, 50% of which had the expected insert size based on restriction digests of 10 random clones. To screen for conditionally lethal mutants, the library was transformed into the haploid strain CUY1111. Transformants were replica-plated onto 5-FOA plates at 26°C to select colonies that had lost the *URA3* plasmid. The 5-FOA--resistant colonies were replica-plated onto three YPD plates that were then incubated at 14°C, 26°C, and 37°C, respectively. 24 heat-sensitive mutants were identified; no cold-sensitive mutants were found.

The *spc72-2* allele was integrated into the yeast chromosome as follows: the plasmid containing *spc72-2* was recovered from yeast and called pXC279; a 1.7-kb BamHI--BamHI fragment containing the *HIS3* gene was cloned into the BgII site of pXC279, which resides 80 bp downstream of the *spc72-2* stop codon; and the resulting plasmid was digested with BamHI and ApaLI to release a 5.2-kb fragment containing *spc72-2* and *HIS3*. This fragment was transformed into diploid strain CUY1109. His^+^ and Ura^−^ transformants were sporulated and dissected. Tetrads with four viable spores contained two Ts^+^ and two Ts^−^ progeny. The Ts^−^ spores were always His^+^, and harbored the *spc72-2* allele.

Fluorescence and Electron Microscopy
------------------------------------

GFP was visualized in living cells or in cells fixed with formaldehyde as described below. Microtubules and SPBs were visualized by immunofluorescence using β- and γ-tubulin antibodies, respectively, as previously described ([@B25]). Cells were fixed for 2 h to visualize microtubules alone. They were fixed for 25 min to visualize both Spc72-GFP and microtubules; the green fluorescence of Spc72p-GFP was sensitive to fixation, but regained fluorescence with reduced intensity after removing formaldehyde. Cells were also fixed for 25 min to visualize SPBs. Rabbit anti-yeast γ-tubulin (Tub4p) antibody was a gift from T. Stearns (Stanford University, Stanford, CA), and was preabsorbed with wild-type fixed yeast spheroplasts overnight at 4°C before use. Rabbit anti-yeast β-tubulin (Tub2p) antibody was a gift from F. Solomon (Massachusetts Institute of Technology, Cambridge, MA). Rhodamine-conjugated goat anti--rabbit and fluorescein-conjugated goat anti--rabbit secondary antibodies were purchased from Organon Teknika-Cappel (Durham, NC). DNA was stained with 4′,6-diamidino-2-phenylindole (DAPI). Electron microscopy was performed as described by [@B7].

Results {#Results}
=======

Two-hybrid Screen Identifies Spc72p as a Protein That Interacts with Stu2p
--------------------------------------------------------------------------

A yeast two-hybrid screen was carried out to identify proteins that interact with Stu2p. Full-length Stu2p fused to the COOH-terminal end of the Gal4p DNA-binding domain served as the bait. We identified 10 cDNA clones encoding proteins that interact with Stu2p, but not with the unrelated protein, Snf1p. Partial sequencing of each cDNA insert showed that these 10 clones were derived from 6 genes. Two different cDNA clones were from the *STU2* gene itself. One clone was from *TUB1,* and one was from *TUB3*, the two yeast genes encoding α-tubulins ([@B28]). Three different clones were from *BIK1*; Bik1p has been previously implicated in microtubule function ([@B3]; [@B26]). Two clones were derived from an open reading frame on chromosome V, YER016w. This open reading frame has recently been identified as encoding a protein that interacts with Tub1p in the two-hybrid screen, and is called *BIM1* ([@B29]). The last clone was from an uncharacterized open reading frame on chromosome I, YAL047c, which we call *SPC72* for reasons given below.

*SPC72* encodes a 622--amino acid protein with a predicted molecular weight of 72 kD. It does not have significant sequence similarity to any proteins in the database. Spc72p is predicted to have an α-helical secondary structure throughout much of its length, and has five predicted coiled-coil regions ([@B21]) that together make up 45% of the protein. The cDNA clone obtained from the library encodes residues 110-484 of Spc72p, indicating that this sequence contains the region of Spc72 necessary for its interaction with Stu2p.

SPC72 is Essential for Growth
-----------------------------

To determine whether *SPC72* is essential for cell viability, we replaced one copy of *SPC72* in a diploid strain with the *HIS3* gene (See Materials and Methods). The His^+^ diploid was sporulated, and 30 tetrads were dissected. Most of the tetrads contained two His^−^ spores that were able to form colonies, and two spores that were unable to form colonies after 3 d at 26°C. The two spores that did not form colonies presumably contained the *spc72-Δ1*::*HIS3* disruption. After 5 d at 26°C, ∼30% of these *spc72-Δ1*::*HIS3* spores grew enough to form very small yet visible colonies; the other 70% of spores colonies contained \<20 cells. When the small colonies were picked and inoculated into liquid YPD, growth was imperceptible.

A plasmid shuffle experiment ([@B31]) also established that *SPC72* is essential for cell growth. We constructed a strain (CUY1111) that has a chromosomal disruption of *SPC72* and *SPC72* on a *URA3*-based plasmid. This strain could not grow on plates containing 5-FOA, a drug that is lethal to cells expressing the *URA3* gene. In contrast, 5-FOA--resistant colonies were obtained if an additional copy of *SPC72* was introduced on a *LEU2*-based plasmid. Taken together, these data indicate that Spc72p is essential for mitotic growth.

Spc72p Interacts with Stu2p In Vivo
-----------------------------------

Because Spc72p was identified as a protein that interacts with Stu2p in the two-hybrid system, we investigated whether Spc72p and Stu2p normally interact in yeast cells. We constructed a fusion between *SPC72* and the sequence encoding the myc epitope tag. This construct is able to complement a *SPC72* deletion, indicating that it is functional. Extracts were made from a yeast strain expressing Spc72-myc, and Spc72-myc was immunoprecipitated using anti-myc antibodies. The precipitated material was separated by SDS-PAGE, and immunoblotting was performed using anti-Stu2p antibodies. As shown in Fig. [1](#F1){ref-type="fig"} (lane *1*), Stu2p coprecipitates with Spc72-myc. As controls, the immunoprecipitation was performed in the absence of anti-myc antibodies (Fig. [1](#F1){ref-type="fig"}, lane *2*) or using cell extracts lacking Spc72-myc (Fig. [1](#F1){ref-type="fig"}, lane *3*). In either case, no Stu2p was precipitated.

Spc72p Interacts with Itself In Vivo
------------------------------------

We found that Spc72p interacts with itself in the two- hybrid system. Y190 cells containing two plasmids that express Gal4[ad]{.smallcaps}-Spc72p and Gal4[bd]{.smallcaps}-Spc72p, respectively, grow on 3-amino-triazole plates and produce β-galactosidase activity. To test whether Spc72p normally interacts with itself in vivo, a coimmunoprecipitation experiment was performed. We constructed a yeast strain that expresses two epitope-tagged versions of Spc72p: the Spc72-myc protein mentioned above and Spc72-HA that is also able to substitute functionally for Spc72p in vivo. Spc72-myc was immunoprecipitated from extracts of this strain using the anti-myc antibody, and the immunoprecipitated material was analyzed for the presence of Spc72-HA by immunoblotting with anti-HA antibodies. As shown in Fig. [1](#F1){ref-type="fig"} (lane *4*), Spc72-HA coimmunoprecipitated with Spc72-myc. Spc72-HA, like Spc72-myc (not shown), migrated as a doublet.

Spc72p Is a Component of the SPB
--------------------------------

A fusion between *SPC72* and the coding region of GFP was constructed to visualize Spc72p in living cells. This *SPC72-GFP* construct, carried on either a low-copy YCp plasmid or a high-copy YEp plasmid, was able to complement the *spc72-Δ1*::*HIS3* disruption. Spc72-GFP was visualized in *spc72-Δ1*::*HIS3* cells containing these plasmids. The fluorescence intensity was generally stronger when the YEp plasmid was used, but the pattern of staining was similar in cells containing either plasmid (Fig. [2](#F2){ref-type="fig"}). In living cells, one bright fluorescent dot was observed in unbudded cells, and two dots were generally observed in budded cells. In small-budded cells, the two dots were either adjacent to or separated by ∼1 μm. In large budded cells, the two fluorescent dots were often segregated into each cell body. The intensity of staining did not appear to change over the course of the cell cycle. When cells were grown in the presence of DAPI, we observed that the Spc72-GFP dots resided at the periphery of the nuclear DNA (Fig. [2](#F2){ref-type="fig"}).

This localization pattern suggested that Spc72p was likely a component of the SPB. To determine directly whether Spc72p localizes to the SPB, we compared Spc72-GFP localization with that of yeast γ-tubulin, Tub4p. Tub4p could be visualized by immunofluorescence after fixation of cells with formaldehyde, but this treatment reduced the Spc72-GFP signal. For this reason, we used another strain in which Spc72-GFP was produced at higher levels from the *GAL1* promoter. In \>95% of the cells, the Spc72-GFP dots were coincident with the dots stained by anti-Tub4p antibodies (Fig. [3](#F3){ref-type="fig"} *A*). Overexpression of Spc72-GFP did not have a deleterious effect on cell growth, and microtubules appeared normal by immunofluorescence microscopy (not shown).

We also tested whether newly synthesized Spc72p is able to associate with an existing SPB. A *SPC72* strain containing a plasmid that expresses *SPC72-GFP* from the *GAL1* promoter was grown in glucose-containing medium to repress synthesis of Spc72-GFP. These cells were arrested with α-factor, and then the synthesis of the Spc72p-GFP was induced by galactose in the continued presence of α-factor. Cells arrested with α-factor possess a single SPB ([@B6]), so any fluorescence observed at the SPB must be due to association of new Spc72p-GFP with that SPB. After 5 h of induction, Spc72p-GFP was observed at the SPB (data not shown). A similar time course of Spc72p-GFP incorporation into the SPB was observed for mitotically growing cells. Thus, Spc72p can be incorporated into a preexisting SPB.

To determine whether the association of Spc72p with the SPB depends on the presence of microtubules, cells expressing Spc72-GFP were treated with a microtubule- depolymerizing drug nocodazole. After this treatment, microtubules were no longer observed by immunofluorescence (Fig. [3](#F3){ref-type="fig"} *B*). Nocodazole treatment did not affect the number of cells containing the Spc72p-GFP signal, or noticeably change the intensity of staining compared with untreated cells. Thus, the association of Spc72p with the SPB is independent of the presence of detectable microtubules. Although we cannot rule out the possibility that nocodazole-treated cells may contain short microtubules at the SPB that cannot be observed by immunofluorescence, this result suggests that Spc72p is an integral component of the SPB.

Spc72p Does Not Bind Microtubules In Vitro
------------------------------------------

We have previously shown that Stu2p is able to bind microtubules in vitro ([@B41]). A similar assay was performed to determine whether Spc72p is able to interact with microtubules as well. We included Stu2p as a positive control for microtubule binding. ^35^S-labeled Spc72p and Stu2p were synthesized by in vitro transcription and translation, and were incubated separately with 5 μM taxol-stabilized bovine brain microtubules. The microtubules were then pelleted by centrifugation, and the pellet and supernatant fractions were analyzed by SDS-PAGE. Because in vitro transcription and translation often produces truncated proteins, only the upper bands in each lane corresponding to the full-length proteins were quantitated. As expected, most of the Stu2p (95%) pelleted with the microtubules (Fig. [4](#F4){ref-type="fig"}). We previously showed that the *K* ~d~ for Stu2p binding to microtubules is ∼0.5 μM, so 5 μM tubulin is approximately ten times the concentration of tubulin that is required to cosediment 50% of the Stu2p ([@B41]). In contrast, no detectable Spc72p was pelleted with this amount of microtubules.

spc72 Mutant Cells are Defective in Nuclear Migration and Division
------------------------------------------------------------------

To determine the role of Spc72p in vivo, we created temperature-sensitive *spc72* mutants. The *SPC72* gene was mutagenized by error-prone PCR in vitro, and temperature-sensitive mutants were identified by the strategy described in Materials and Methods. The *spc72-2* mutant displayed the best conditional growth properties, and was chosen for the phenotypic analysis. *spc72-2* cells were grown at their permissive temperature (26°C), and were then shifted to the restrictive temperature (37°C). After 3 h at 37°C, the *spc72-2* culture showed a modest increase in the fraction of cells with large buds. More than 40% of the *spc72-2* cells were large-budded, compared with ∼20% in the *SPC72* population. DAPI staining of chromosomal DNA indicated that this inhibition of cell cycle progression is due to a defect in chromosome segregation (Table [III](#TIII){ref-type="table"}). More than 70% of *spc72-2* large-budded cells contained unsegregated chromosomes. In contrast, only ∼30% of the *SPC72* cells had failed to segregate chromosomes by the time they had produced large-buds.

Although the nuclear division defect in *spc72-2* cells does slow the progression of cells through the cell cycle, it does not produce a cell cycle block. At 37°C, we observed a significant fraction of unbudded cells that lacked nuclear DNA (Table [III](#TIII){ref-type="table"}; see Fig. [6](#F6){ref-type="fig"}). These cells were presumably generated by cytokinesis of large-budded cells that had failed to segregate chromosomes properly into their bud. As expected, the percentage of anucleate unbudded cells increased with time at 37°C. In addition, flow cytometry showed that *spc72-2* cells can undergo a second round of DNA replication in the absence of chromosome segregation (Fig. [5](#F5){ref-type="fig"}). At 26°C, the *spc72-2* culture contained cells with a typical 1C (pre-DNA replication) and 2C (post-DNA replication) DNA content. A small percentage of the cells containing a 4C DNA content were also present, indicating a partial defect in chromosome segregation, even at permissive temperature. This 4C peak became more prominent with increasing time at restrictive temperature, and by 6 h represented about half of the population.

*spc72-2* cells also showed defects in nuclear migration at the restrictive temperature (Table [III](#TIII){ref-type="table"}). Before nuclear division, chromosomes in large-budded *SPC72* cells were invariably located near the bud neck. In contrast, in nearly all of the *spc72-2* cells that were large-budded and contained an undivided nucleus, the chromosomes were located away from the bud neck. In addition, 75% of the *spc72-2* cells that did complete chromosome separation contained two nuclei in a single cell body. This latter phenotype also indicates a defect in nuclear migration before mitosis.

To determine whether Spc72p is necessary to maintain the nucleus at the bud neck, we treated *spc72-2* cells with hydroxyurea at 26°C. This treatment causes cells to arrest with large buds and a single undivided nucleus. In the *spc72-2* population, 85% of these cells contained a nucleus positioned at the bud neck. These cells were then shifted to 37°C for 30 min in the continued presence of hydroxyurea. After this temperature shift, only 40% of the large-budded cells still contained their nuclei at the bud neck. Thus, Spc72p plays a role in maintaining the nucleus at the bud neck.

spc72 Mutant Cells Display Defects in Microtubule Assembly
----------------------------------------------------------

The defects in nuclear migration and division observed in *spc72-2* cells suggest that this mutation affects microtubule assembly. The microtubule cytoskeleton in *spc72-2* cells was examined by immunofluorescence microscopy. The most dramatic effect of the *spc72-2* mutation was on the assembly of cytoplasmic microtubules. After 2 h at 37°, most *spc72-2* cells contained only a dot of staining near the periphery of the chromosomal DNA or a bar of staining that stretched across the chromosomal DNA region (Fig. [6](#F6){ref-type="fig"} *B*). The dots presumably indicate the presence of short microtubules at the SPBs, and the bars represent spindle microtubules. Unlike *SPC72* cells (Fig. [6](#F6){ref-type="fig"} *D*), *spc72-2* cells rarely contained microtubule fibers that extended from the SPBs in the cytoplasm.

The *spc72-2* mutation did not block the formation of a short mitotic spindle. After 2 h at 37°C, \>75% of the *spc72-2* large-budded cells had a mitotic spindle coincident with the chromosomal DNA (Fig. [6](#F6){ref-type="fig"} *B* and Fig. [7](#F7){ref-type="fig"}). The majority of these contained two separated SPBs, as visualized with γ-tubulin antibody (data not shown), indicating that the spindles observed were in fact bipolar. Most of these spindles (∼75%) were the same length as normal short preanaphase spindles (Fig. [6](#F6){ref-type="fig"}, *B* and *C*, and Fig. [7](#F7){ref-type="fig"}, *A--C*). About 15% contained longer spindles that were up to two times the length of a normal short spindle (Fig. [7](#F7){ref-type="fig"} *D*). Relatively few cells (\<10%) contained a typical long anaphase spindle that extended the length of the cell, as observed in *SPC72* cells (Fig. [6](#F6){ref-type="fig"} *D*). Overall, these results indicate that spindle elongation is substantially inhibited in *spc72-2* cells. In cells containing elongated spindles, some degree of chromosome separation was usually observed, but the spindles and chromosomes often remained entirely within the mother cell (Fig. [7](#F7){ref-type="fig"} *D*). As mentioned above, the majority (∼75%) of *spc72-2* cells that contained spindles had no detectable cytoplasmic microtubules (Fig. [6](#F6){ref-type="fig"}, *B* and *C,* and Fig. [7](#F7){ref-type="fig"} *A*). However, a few of these cells (∼15%) had an excessively long bundle of cytoplasmic microtubules emanating from only one spindle pole (Fig. [7](#F7){ref-type="fig"} *B*; compare to cytoplasmic microtubules in *SPC72* cells in Fig. [6](#F6){ref-type="fig"} *D*). In addition, cytoplasmic microtubules that were not attached to either pole were observed in ∼10% of these cells (Fig. [7](#F7){ref-type="fig"} *C*).

The unbudded anucleate *spc72-2* cells that accumulated with time at 37°C lacked all microtubules (Fig. [6](#F6){ref-type="fig"} *C*). In addition, there was a corresponding increase in the number of *spc72-2* cells with multiple microtubule foci (Fig. [6](#F6){ref-type="fig"} *C*). Both of these classes of cells likely arise from cytokinesis of a large-budded cell that has failed to move a SPB into the bud. In this case, one daughter will lack SPBs. The other will obtain two SPBs that can subsequently duplicate and separate to produce a cell with multiple microtubule-organizing centers.

To assess the primary defect caused by the *spc72-2* mutation, we synchronized cells with α-factor at 26°C, and then released them from the α-factor block and incubated them in fresh medium at 37°C. 90 min after release, most cells contained large buds. 90% of these large-budded cells contained a short bipolar spindle, as determined by microtubule and SPB staining, and an undivided nucleus (data not shown). In nearly all of these cells, the nucleus failed to migrate to the bud neck, and was randomly positioned in one cell body. As in asynchronous cultures, very few cytoplasmic microtubules were observed; those few that were observed were excessively long. At later times after release from α-factor, we observed an increasing number of unbudded anucleate cells and cells with multiple SPBs.

These aberrant microtubule phenotypes were also observed in *spc72-2* cells grown at 26°C, but to a much lesser extent (Fig. [6](#F6){ref-type="fig"} *A*). Thus, even 26°C is not entirely permissive for microtubule assembly in *spc72-2* cells.

SPB Morphology in spc72 Mutant Cells
------------------------------------

*spc72-2* cells were also examined by thin section electron microscopy. Cells were arrested in α-factor and then released from the block at 37°C for 90 min. As described above, this protocol allowed us to examine a more uniform population than that which could be obtained from asynchronous cultures. Fig. [8](#F8){ref-type="fig"} *A* shows a short bipolar spindle in one of these *spc72-2* cells. It is of normal length (1.2 μm) for a preanaphase spindle, and contains organized microtubule arrays typical of those observed in *SPC72* cells. We identified about 50 SPBs in both *SPC72* and *spc72-2* cells by their characteristic dark-staining central plaques. In both cell types, we could also observe a distinct outer plaque in about 20% of these SPBs. The outer plaques of *spc72-2* cells displayed a couple of subtle but consistent differences (Fig. [8](#F8){ref-type="fig"} *B*, *SPC72*; Fig. [8](#F8){ref-type="fig"}, *C* and *D*, *spc72-2*). First, the distance between the central and outer plaques is about twice as large in *spc72-2* cells. Second, the outer plaques of *spc72-2* cells appeared to contain discontinuities or small gaps that were not observed in *SPC72* outer plaques (Fig. [8](#F8){ref-type="fig"}, *C* and *D*, *arrows*). Inner plaques could not be observed in sufficient detail to allow any meaningful comparison of these structures.

Discussion {#Discussion}
==========

Stu2p Associates with Spc72p In Vivo
------------------------------------

We carried out a two-hybrid screen to identify proteins that interact with Stu2p, a microtubule-associated protein that localizes primarily to the SPB. As expected, we identified genes encoding tubulins, specifically the two α-tubulins. We do not believe this result can be taken as evidence that Stu2p interacts directly with α-tubulin, as opposed to β-tubulin, because the Gal4[ad]{.smallcaps}-α-tubulin is likely to dimerize with β-tubulin in the cell. Thus, Stu2p could interact exclusively with β-tubulin and still activate transcription through the Gal4[ad]{.smallcaps}-α-tubulin-β-tubulin dimer. We did not expect to identify the gene encoding β-tubulin because genes are expressed at high levels in the two-hybrid system, and overexpression of β-tubulin is known to be lethal ([@B42]).

Bik1p and Bim1p were also identified in this screen. Bik1p was originally identified as a protein that is essential for karyogamy ([@B3]). Bik1p localizes to the SPB and spindle microtubules in vivo, and cells lacking Bik1p show defects in microtubule assembly. Bim1p was recently identified as a protein that interacts with α-tubulin in a two-hybrid screen ([@B29]). It localizes to both spindle and cytoplasmic microtubules, and cells lacking Bim1p display aberrant spindle morphology. It is possible that the Bik1p and Bim1p are components of a Stu2p complex given their interactions with Stu2p in the two-hybrid assay. However, both Bik1p and Bim1p are believed to be microtubule-binding proteins, so these interactions observed in the two-hybrid assay could be indirect and mediated by tubulin. Further experiments are needed to clarify this issue.

The two-hybrid screen also identified Stu2p and Spc72p. We showed that Spc72p and Stu2p can be coimmunoprecipitated from yeast extracts, indicating that they form a complex. In addition to interacting with itself in the two-hybrid assay, differentially epitope-tagged Stu2p\'s can be coimmunoprecipitated (K. Kosco, unpublished data). Similarly, Spc72p interacts with itself in the two-hybrid assay, and differentially epitope-tagged Spc72p\'s can also be coimmunoprecipitated. One interpretation of these results is that the Stu2p--Spc72p complex contains more than one molecule of both Stu2p and Spc72p. Alternatively, cells may contain Stu2p-Stu2p, Spc72p-Spc72p, and Stu2p-Spc72p dimers that do not interact with each other.

Spc72p is a Component of the SPB
--------------------------------

A Spc72-GFP fusion protein localizes to the SPB, indicating that Spc72p, like Stu2p, is a component of the yeast SPB. We believe the localization of Spc72-GFP reflects that of endogenous Spc72p because *SPC72-GFP* is able to rescue the lethality of a *spc72* null mutation. Spc72-GFP localization is not affected by treatment of cells with nocodazole, which eliminates all detectable microtubules. Although we cannot rule out the possibility that a small amount of tubulin polymer that is undetectable by immunofluorescence may remain at the SPB after treatment with nocodazole, this result is consistent with the interpretation that Spc72p is an integral component of the SPB. We did not observe even minor amounts of Spc72-GFP along microtubules as we did for Stu2-GFP. This difference may reflect the fact that Stu2p is capable of interacting directly with microtubules, and that Spc72p lacks this ability (see below).

The association of Spc72p with the SPB was examined in more detail by expressing *SPC72-GFP* under the control of the *GAL1* promoter. When Spc72-GFP was produced in α-factor--arrested cells, it localized to the existing SPB. This result indicates that Spc72p can associate with an SPB that is already assembled. A similar result was obtained for the yeast γ-tubulin Tub4p ([@B22]). In contrast, another SPB protein, Kar1p, was found to associate only with a new SPB after induction ([@B39]). Thus, Spc72p and Tub4p may represent more peripheral components of the SPB that can exchange with their soluble subunits, respectively. This possibility would be consistent with their proposed roles as proteins that interact directly or indirectly with microtubules that contact the inner and outer surfaces of the SPB.

We have shown previously that Stu2p can bind laterally to microtubules in vitro with an affinity that is comparable to that of other known microtubule-associated proteins ([@B41]). In contrast, we could not detect any binding of Spc72p to microtubules, even at tubulin concentrations greater than ten times the *K* ~d~ for Stu2p binding. Thus, we conclude that Spc72p does not bind significantly to the sides of microtubules. However, because Spc72p is a component of the SPB, it is reasonable to consider the possibility that it may bind to the ends of microtubules. Microtubules used in the binding assay are on average ∼10 μm in length ([@B41]). Assuming 1,700 tubulin dimers per μm microtubule ([@B23]), the concentration of minus ends in this preparation is ∼3 × 10^−10^ M. For comparison, the *K* ~d~ for γ-tubulin binding to the minus ends of microtubules is ∼1.5 × 10^−10^ M. Therefore, our results indicate that Spc72p does not have an affinity for the ends of microtubules comparable to that of γ-tubulin.

Spc72p Plays a Role in Microtubule Assembly and Function
--------------------------------------------------------

The *spc72-2* mutant cells are clearly deficient in cytoplasmic microtubules; the majority of cells contain no cytoplasmic microtubules that can be detected by immunofluorescence microscopy. This phenotype indicates that Spc72p plays a role in the assembly and/or stability of microtubules at the cytoplasmic surface of the SPB or outer plaque. In support of this conclusion, we also observed subtle but consistent defects in the morphology of the outer plaques in *spc72-2* cells. Recently, Spc72p has been localized to the outer plaque using immunoelectron microscopy of isolated SPBs ([@B16]). This result agrees with our observations of *spc72-2* cells.

We observed a single long cytoplasmic microtubule in a minority of the *spc72-2* cells. Interestingly, in many cases these cytoplasmic microtubules were not attached to the SPB, indicating that they had been released from the SPB after their assembly. We previously suggested that Stu2p may play a role in tethering microtubules to the SPB through its ability to bind laterally to microtubules. The observation of free cytoplasmic microtubules in *spc72-2* cells supports the hypothesis that Stu2p, in conjunction with Spc72p, does play a role in microtubule tethering. We expect that these free microtubules would be relatively unstable, which could account for the fact that they are observed in only a small percentage of cells. Their excessive length may be a secondary consequence of a *spc72-2* defect. When fewer microtubules are being assembled, those few that are may be able to draw on a larger pool of soluble tubulin and achieve greater length.

In contrast to their severe defect in cytoplasmic microtubule assembly, most *spc72-2* cells are able to assemble bipolar spindles. However, the *spc72-2* mutation greatly inhibits spindle elongation. It is unlikely that the spindle elongation defect is a direct consequence of the lack of cytoplasmic microtubules. A conditional lethal mutation in the gene encoding β-tubulin that specifically inhibits cytoplasmic microtubule assembly does not block spindle elongation or chromosome segregation ([@B38]). In addition, several lines of reasoning argue against the idea that the defect in spindle elongation is due to a cell cycle block. First, although the *spc72-2* mutation appears to slow progression through mitosis, it does not cause a cell cycle block. The mutation does not block cytokinesis, as implied by the production of unbudded cells with little or no DNA, additional rounds of DNA replication as shown by flow cytometry, or the SPB duplication cycle as indicated by cells with multiple SPBs. Second, a number of cells do contain slightly elongated spindles, suggesting that they have entered anaphase, but are physically incapable of further spindle elongation. Thus, we conclude that the *spc72-2* mutation has a direct effect on spindle elongation.

The mechanisms for spindle pole separation during spindle assembly are likely to be similar to those that increase spindle pole separation during anaphase B elongation. Both processes are thought to be mediated by motor proteins that act to push antiparallel polar microtubules past each other in a direction that forces the poles apart ([@B1]; [@B40]). In *S. cerevisiae*, this pushing force is produced by the kinesin-like motors Cin8p and Kip1p ([@B14]). Because the fully elongated yeast spindle is many times the length of its short preanaphase spindle, polar microtubules must lengthen substantially as anaphase separation proceeds. One explanation for the *spc72-2* phenotype is that *spc72-2* cells are able to assemble the microtubules necessary to form a bipolar spindle, but are unable to assemble spindle microtubules of sufficient length to accomplish spindle elongation. While we do not yet know the mechanism by which Spc72p could influence spindle microtubule length, the fact that the *spc72-2* mutation causes a defect in spindle elongation suggests that it affects the nuclear surface of the SPB or inner plaque. Immunoelectron microscopy did not identify Spc72p on the inner plaque ([@B16]); however, it is difficult to rule out the possibility that Spc72p is located in this structure while the antigen is masked. Alternatively, Spc72p may be located exclusively in the outer plaque, but the defect caused by the *spc72-2* mutation perturbs the SPB sufficiently to affect its function on the intranuclear side as well.
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DAPI

:   4′,6-diamidino-2-phenylindole

DIC

:   differential interference contrast

5-FOA

:   5-fluoroorotic acid

GFP

:   green fluorescent protein

HA

:   hemagglutinin

SPB

:   spindle pole body

YPD

:   yeast extract peptone dextrose

###### 

Yeast Strains

  Strain       Genotype                                                                              Source
  --------- -- ---------------------------------------------------------------------------------- -- -----------------------
  CUY26        *MATα his3-Δ200 leu2-3, 112 ura3-52*                                                  This study
  CUY546       *MATa/MATα ade2/ADE2 his3-Δ200/his3-Δ200*                                             This study
                 *leu2-3, 112/leu2-3, 112 ura3-52/ura3-52*                                           
  CUY1109      *MATa/MATα spc72-Δ1*::*URA3/SPC72 ade2/ADE2*                                          This study
                 *his3-Δ200/his3-Δ200 leu2-3, 112/leu2-3, 112 ura3-52/ura3-52*                       
  CUY1110      *MATa/MATα spc72-Δ1*::*HIS3/SPC72 ade2/ADE2*                                          This study
                 *his3-Δ200/his3-Δ200 leu2-3, 112/leu2-3, 112 ura3-52/ura3-52*                       
  CUY1111      *MATa spc72-Δ1*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52* (pXC255, *SPC72 URA3*)          This study
  CUY1112      *MATa spc72-Δ1*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52* (pXC214, *SPC72 LEU2*)          This study
  CUY1113      *MATa spc72-Δ1*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52* (pXC226, *SPC72-GFP LEU2*)      This study
  CUY1114      *MATa spc72-Δ1*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52* (pXC224, *SPC72-GFP LEU2*)      This study
  CUY1115      *MATa URA3*::*P[gal1]{.smallcaps}-SPC72-GFP*::*ura3-52 his3-Δ200 leu2-3, 112*         This study
  CUY1116      *MATa spc72-Δ1*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52* (pXC279, *spc72-2 LEU2*)        This study
  CUY1123      *MATa spc72-2*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52*                                  This study
  CUY1124      *MATa spc72-Δ1*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52* (pXC264, *SPC72-myc URA3*)      This study
  CUY1125      *MATa spc72-Δ1*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52*                                 This study
                (pXC264, SPC72-myc URA3; pXC265, SPC72-HA LEU2)                                      
  CUY1128      *MATa spc72-Δ1*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52* (pXC265, *SPC72-HA LEU2*)       This study
  CUY1130      *MATa leu2-3, 112 his3-Δ200 ura3-52*                                                  This study
  CUY1137      *MATα spc72-2*::*HIS3 leu2-3, 112 his3-Δ200 ura3-52*                                  This study
  Y190         *MATa ade2-101 cyh^R^ gal4 gal80 his3 leu2-3, 112 trp1-901*                           S. Elledge (Baylor
                 *ura3-52 URA3*::GAL(UAS)-lacZ LYS2::GAL(UAS)-HIS3                                    College of Medicine)

###### 

Plasmids

  Plasmid        Class      Relevant markers                                                Source
  ----------- -- ------- -- ------------------------------------------------------------ -- -------------------------------------------
  pACT2          YEp        *P[adh]{.smallcaps}-GAL4[ad]{.smallcaps}-HA LEU2*               S. Elledge  (Baylor College  of Medicine)
  pAS2           YEp        *P[adh]{.smallcaps}-GAL4[bd]{.smallcaps}-HA TRP1  CYH2*         S. Elledge  (Baylor College  of Medicine)
  pAS1-SNF1      YEp        *P[adh]{.smallcaps}-GAL4[bd]{.smallcaps}-SNF1 TRP1*             S. Elledge  (Baylor College  of Medicine)
  pXC180         YEp        *P[adh]{.smallcaps}-GAL4[bd]{.smallcaps}-STU2 TRP1  CYH2*       This study
  pXC204         pCRII      *SPC72*                                                         This study
  pXC214         YCp        *SPC72 LEU2*                                                    This study
  pXC219         YEp        *P[adh]{.smallcaps}-GAL4[ad]{.smallcaps}-SPC72  LEU2*           This study
  pXC224         YCp        *SPC72-GFP LEU2*                                                This study
  pXC226         YEp        *SPC72-GFP LEU2*                                                This study
  pXC231         YCp        *P[gal1]{.smallcaps}-SPC72 URA3*                                This study
  pXC248         YCp        *SPC72-myc LEU2*                                                This study
  pXC254         YCp        *P[gal1]{.smallcaps}-SPC72 LEU2*                                This study
  pXC255         YCp        *SPC72 URA3*                                                    This study
  pXC262         YEp        *SPC72-myc LEU2*                                                This study
  pXC264         YEp        *SPC72-myc URA3*                                                This study
  pXC265         YCp        *SPC72-HA LEU2*                                                 This study
  pXC266         YCp        *P[gal1]{.smallcaps}-SPC72-GFP  LEU2*                           This study
  pXC279         YCp        *spc72-2 LEU2*                                                  This study
  pXC281         YEp        *P[adh]{.smallcaps}-GAL4[bd]{.smallcaps}-SPC72  TRP1 CYH2*      This study

![Spc72p coimmunoprecipitates with Stu2p and itself. Protein extracts from the yeast strains indicated were immunoprecipitated (*IP*) with anti-myc antibody or were mock-immunoprecipitated without antibody. Immunoprecipitates were subjected to SDS-PAGE, and the gels were immunoblotted with anti-Stu2p or anti-HA antibodies as indicated. CUY1124 contains Spc72-myc, CUY26 contains no epitope-tagged constructs, CUY1125 contains Spc72-myc and Spc72-HA, and CUY1128 contains Spc72-HA.](JCB9802066.f1){#F1}

![Localization of Spc72-GFP. GFP fluorescence was visualized in living yeast cells that contain a disruption of the chromosomal *SPC72* gene and carry *SPC72-GFP* on a plasmid (CUY1113). To visualize chromosomal DNA, cells were grown in the presence of 1 μg/ml DAPI for 2 h. (*Top*) Both DNA staining and differential interference contrast (*DIC*) image of cells; (*bottom*) fluorescence of Spc72-GFP. Bar, 5 μm.](JCB9802066.f2){#F2}

![Spc72p localization to the SPBs is independent of microtubules. Yeast strain CUY1115, expressing *SPC72-GFP* under control of the *GAL1* promoter, was grown in YPGal at 26°C. (*A*) Cells were fixed for immunofluorescence and stained with anti-Tub4p antibodies. (*B*) Cells were treated with nocodazole to depolymerize microtubules, and were stained with anti-β-tubulin antibody. DAPI staining and DIC images are also shown. Bar, 5 μm.](JCB9802066.f3){#F3}

![Spc72p does not bind microtubules in vitro. ^35^S-labeled in vitro--translated Stu2p and Spc72p were incubated without microtubules (−) and with 5 μM taxol-stabilized bovine brain microtubules (+). Microtubules were then pelleted by centrifugation, and pellet (*P*) and supernatant (*S*) fractions were subjected to SDS-PAGE analysis. Bands were visualized and quantitated using a phosphoimager.](JCB9802066.f4){#F4}

###### 

Cell and Nuclear Morphology of spc72-2 Cells

                 Temp      Time                                                                        
  ----------- -- ------ -- ------ -- ---- -- ---- -- --- -- ---- -- --- -- ---- -- ---- -- ---- -- --- --
                 *°C*      *h*                                                                         
  *SPC72*        26                  41       0      0      33      0       0      10      16      0   
  *SPC72*        37        3         56       0      0      28      0       0       5      11      0   
  *spc72-2*      26                  35       3      2      28      1       7       5      15      4   
  *spc72-2*      37        3         21      12      1      21      2      30       1       3      9   
  *spc72-2*      37        6         14      28      1      13      2      31       4       2      5   

*SPC72* (CUY26) and *spc72-2* (CUY1123) cells were grown at 26°C, shifted to 37°C for the times indicated, and stained with DAPI. Table shows the percentages of cells with a given cellular morphology (unbudded, small-budded, or large-budded) and chromosomal DNA distribution. For each time point, \>100 cells were counted.  

![Phenotype of *spc72-2* cells. *spc72-2* (CUY1123) and *SPC72* (CUY26) cells were grown at 26°C, and were then shifted to 37°C for the times indicated. (*A*) *spc72-2* cells at 26°C; (*B*) *spc72-2* cells after 2 h at 37°C; (*C*) *spc72-2* cells after 4 h at 37° C; (*D*) *SPC72* cells after 2 h at 37°C. (*A--D*) DIC; (*A*′--*D*′), DAPI staining; (*A*′′--*D*′′), immunofluorescence with Tub2p antibody. Bar, 10 μm.](JCB9802066.f6){#F6}

![DNA content of *spc72-2* cells. CUY1123 cells were grown to logarithmic phase at 26°C, and were then shifted to 37°C. Aliquots of cells were taken 2, 4, and 6 h after the temperature shift. Flow cytometry was performed as described by [@B15]. The positions of cells with 1C and 2C DNA content were determined by flow cytometry of *SPC72* cells (CUY26); the position of cells with a 4C DNA content was extrapolated from this data.](JCB9802066.f5){#F5}

![Phenotype of large-budded *spc72-2* cells. *spc72-2* cells (CUY1123) were grown at 26°C, and were then shifted to 37°C for 2 h. (*A--D*), DIC; (*A*′--*D*′), DAPI staining; (A′′--D′′), immunofluorescence with Tub2p antibody. Arrow indicates microtubule that is unattached to the SPB. Bar, 5 μm.](JCB9802066.f7){#F7}

![Spindle and SPB morphology in *spc72-2* cells. *SPC72* (CUY1130) and *spc72-2* (CUY1116) were arrested with α-factor at 26°C, and were then released from the arrest at 37°C for 90 min. (*A*) *spc72-2* spindle; (*B*) *SPC72* SPB; (*C* and *D*) *spc72-2* SPBs. Arrows indicate gaps in the outer plaque of *spc72-2* cells. Bars, 0.1 μm.](JCB9802066.f8){#F8}
